Advanced in vitro models for renal cell carcinoma therapy design
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-09 · 1878 (5) · 188942
DOI: 10.1016/j.bbcan.2023.188942 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-09. Verfasst von Valentin Mieville und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Faculty of Sciences, University of Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerlan…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Renal cell carcinoma (RCC) and its principal subtype, clear cell RCC, are the most diagnosed kidney cancer. Despite substantial improvement over the last decades, current pharmacological intervention still fails to achieve long-term therapeutic success. RCC is characterized by a high intra- and inter-tumoral heterogeneity and is heavily influenced by the crosstalk of the cells composing the tumor microenvironment, such as cancer-associated fibroblasts, endothelial cells and immune cells. Moreover, multiple physicochemical properties such as pH, interstitial pressure or oxygenation may also play an important role. These elements are often poorly recapitulated in in vitro models used for drug development. This inadequate recapitulation of the tumor is partially responsible for the current lack of an effective and curative treatment. Therefore, there are needs for more complex in vitro or ex vivo drug screening models. In this review, we discuss the current state-of-the-art of RCC models and suggest strategies for their further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Faculty of Sciences, University of Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; Translational Research C…
- Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.
- Division of Urology, Geneva University Hospitals, Geneva, Switzerland.
Zitieren
APA
Mieville, V., Griffioen, A. W., Benamran, D., & Nowak-Sliwinska, P. (2023). Advanced in vitro models for renal cell carcinoma therapy design. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(5), 188942. https://doi.org/10.1016/j.bbcan.2023.188942
Vancouver
Mieville V, Griffioen AW, Benamran D, Nowak-Sliwinska P. Advanced in vitro models for renal cell carcinoma therapy design. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(5):188942. doi:10.1016/j.bbcan.2023.188942
BibTeX
@article{Mieville2023,
author = {Mieville, Valentin and Griffioen, Arjan W and Benamran, Daniel and Nowak-Sliwinska, Patrycja},
title = {Advanced in vitro models for renal cell carcinoma therapy design},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {5},
pages = {188942},
doi = {10.1016/j.bbcan.2023.188942}
}
EUVIMED